4.7 Article

Inhalable vaccine of bacterial culture supernatant extract mediates protection against fatal pulmonary anthrax

Related references

Note: Only part of the references are listed.
Article Immunology

Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation

Wei Zhang et al.

Summary: The study compared the immunoprotection against pneumonic plague provided by different vaccines and different administration methods. The results showed that aerosolized intratracheal delivery of rF1-V10 vaccine in a powder formulation may be a promising strategy to provide protective immunity against pneumonic plague.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Aerosolized Intratracheal Inoculation of Recombinant Protective Antigen (rPA) Vaccine Provides Protection Against Inhalational Anthrax in B10.D2-Hc0 Mice

Xiaolin Song et al.

Summary: Anthrax caused by Bacillus anthracis is a fatal disease and developing a better vaccine is necessary. Immunization with dry powder vaccine via intratracheal route provides a stable and effective strategy to improve currently available anthrax vaccines. B10.D2-Hc(0) mice challenged with attenuated strains may serve as an alternative model for anthrax vaccine candidate screening.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biotechnology & Applied Microbiology

Efficient Genome Editing by a Miniature CRISPR-AsCas12f1 Nuclease in Bacillus anthracis

Yanchun Wang et al.

Summary: Researchers have developed a new method to edit the genome of Bacillus anthracis using the AsCas12f1 nuclease from Acidibacillus sulfuroxidans. The method shows high efficiency and is capable of large-fragment deletion. The length of the homologous arms of the donor DNA is closely related to the editing efficiency. A two-plasmid system was also constructed for potential multi-gene modification.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

Article Multidisciplinary Sciences

Proteomic analysis of differential anther development from sterile/fertile lines in Capsicum annuum L.

Hongxia Pei et al.

Summary: This study identified 45 key proteins associated with anther and pollen development in a male sterile pepper line through proteomic analysis. Additionally, the activities of peroxidase and catalase, as well as the levels of phytohormones, were found to be related to male sterility in pepper.

PEERJ (2022)

Article Immunology

Oral Administration of a Shigella 2aT32-Based Vaccine Expressing UreB-HspA Fusion Antigen With and Without Parenteral rUreB-HspA Boost Confers Protection Against Helicobacter pylori in Mice Model

Xin Zhang et al.

Summary: This study evaluated the immunogenicity and immunoprotective effect of a vaccine candidate against H. pylori. It was found that the candidate vaccine induced specific immune responses and had a preventive effect against H. pylori infection.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Efficacy of the AV7909 anthrax vaccine candidate in guinea pigs and nonhuman primates following two immunizations two weeks apart

Jeffry D. Shearer et al.

Summary: The anthrax vaccine candidate AV7909 is showing promising results in clinical studies, with an enhanced immune response compared to existing vaccines. A vaccination regimen of 0, 2 weeks with AV7909 may provide earlier induction of protective TNA levels, potentially offering benefits over current approved vaccination regimens.

VACCINE (2021)

Article Infectious Diseases

Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial

Shipo Wu et al.

Summary: The study evaluated the safety and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine in adults without COVID-19 from China. It found that the aerosol vaccine was well tolerated, and two doses elicited neutralising antibody responses similar to one dose of intramuscular injection. An aerosolised booster vaccination at 28 days after the first intramuscular injection induced strong IgG and neutralising antibody responses. The efficacy and cost-effectiveness of aerosol vaccination should be evaluated in future studies.

LANCET INFECTIOUS DISEASES (2021)

Article Immunology

Single-dose combination nanovaccine induces both rapid and durable humoral immunity and toxin neutralizing antibody responses against Bacillus anthracis

Sean M. Kelly et al.

Summary: Bacillus anthracis, the causative agent of anthrax, remains a prominent biological warfare and bioterrorism threat. Vaccination is expected to be the most effective public health measure for countering this threat in the foreseeable future. Improvements in adjuvants and delivery platforms are necessary to enhance the effectiveness, stability, and ease-of-use of the anthrax vaccine.

VACCINE (2021)

Article Immunology

Intratracheal inoculation of AHc vaccine induces protection against aerosolized botulinum neurotoxin A challenge in mice

Changjiao Gan et al.

Summary: In this study, intratracheal immunization with recombinant Hc subunit vaccines showed slightly better immune protection and toxin-neutralizing effects against aerosolized BoNT/A intoxication compared to subcutaneous immunization, especially in promoting mucosal secretory IgA production.

NPJ VACCINES (2021)

Article Immunology

Development of a novel multiepitope chimeric vaccine against anthrax

Somya Aggarwal et al.

MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2019)

Article Biochemistry & Molecular Biology

The characteristics of hDPP4 transgenic mice subjected to aerosol MERS coronavirus infection via an animal nose-only exposure device

Xin-yan Hao et al.

ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2019)

Article Critical Care Medicine

Aerosol Delivery Devices for Obstructive Lung Diseases

Roy A. Pleasants et al.

RESPIRATORY CARE (2018)

Article Medicine, Research & Experimental

Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus

Sugandha Saboo et al.

MOLECULAR PHARMACEUTICS (2016)

Article Biochemical Research Methods

The MaxQuant computational platform for mass spectrometry-based shotgun proteomics

Stefka Tyanova et al.

NATURE PROTOCOLS (2016)

Review Microbiology

Anthrax Pathogenesis

Mahtab Moayeri et al.

ANNUAL REVIEW OF MICROBIOLOGY, VOL 69 (2015)

Article Biotechnology & Applied Microbiology

Genome sequence of Bacillus anthracis attenuated vaccine strain A16R used for human in China

Xiankai Liu et al.

JOURNAL OF BIOTECHNOLOGY (2015)

Review Medicine, General & Internal

Anthrax: A disease of biowarfare and public health importance

Ajay Kumar Goel

WORLD JOURNAL OF CLINICAL CASES (2015)

Article Biotechnology & Applied Microbiology

Production and cell surface display of recombinant anthrax protective antigen on the surface layer of attenuated Bacillus anthracis

Yan-chun Wang et al.

WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2015)

Article Chemistry, Medicinal

Stable dry powder formulation for nasal delivery of anthrax vaccine

Sheena H. Wang et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2012)

Review Immunology

Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut

N. J. Mantis et al.

MUCOSAL IMMUNOLOGY (2011)

Review Biotechnology & Applied Microbiology

New developments in dry powder pulmonary vaccine delivery

Tomas Sou et al.

TRENDS IN BIOTECHNOLOGY (2011)

Review Biotechnology & Applied Microbiology

Anthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine

Dennis M. Klinman et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2009)

Review Biochemistry & Molecular Biology

Membrane translocation by anthrax toxin

R. John Collier

MOLECULAR ASPECTS OF MEDICINE (2009)

Article Endocrinology & Metabolism

Inhalation, deposition, and fate of insulin and other therapeutic proteins

Joseph D. Brain

DIABETES TECHNOLOGY & THERAPEUTICS (2007)

Review Pharmacology & Pharmacy

Molecular basis for improved anthrax vaccines

RN Brey

ADVANCED DRUG DELIVERY REVIEWS (2005)

Review Medicine, General & Internal

Anthrax vaccines

M Splino et al.

ANNALS OF SAUDI MEDICINE (2005)

Review Pharmacology & Pharmacy

Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications

NR Labiris et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)